Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri. Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include , , , , , Vectis Life Sciences and . They have invested over $72 million in the company. The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.

Property Value
dbo:abstract
  • Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri. Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include , , , , , Vectis Life Sciences and . They have invested over $72 million in the company. The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing. On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014. (en)
dbo:industry
dbo:type
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2019-06-04 17:28:56Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 18611445 (xsd:integer)
dbo:wikiPageLength
  • 4363 (xsd:integer)
dbo:wikiPageModified
  • 2019-06-04 17:14:15Z (xsd:date)
dbo:wikiPageOutDegree
  • 21 (xsd:integer)
dbo:wikiPageRevisionID
  • 900288613 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri. Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include , , , , , Vectis Life Sciences and . They have invested over $72 million in the company. The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing. (en)
rdfs:label
  • Proteon Therapeutics (en)
owl:sameAs
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Proteon Therapeutics (en)
is foaf:primaryTopic of